AN ACT CLASSIFYING XYLAZINE AS A SCHEDULE IV CONTROLLED SUBSTANCE.
Connecticut bill would classify xylazine as Schedule IV controlled substance to address its emergence in illicit drug supplies and combat trafficking.
Connecticut bill would classify xylazine as Schedule IV controlled substance to address its emergence in illicit drug supplies and combat trafficking.
SB 749 would classify xylazine as a Schedule IV controlled substance under Connecticut law. Xylazine is a veterinary tranquilizer increasingly found in illicit drug supplies, particularly mixed with opioids and fentanyl. This classification would establish legal penalties for unauthorized possession, distribution, and manufacturing of the substance.
Xylazine has emerged as a significant public health concern, appearing in street drug supplies and complicating overdose treatment since it doesn't respond to naloxone (Narcan). Scheduling it would provide law enforcement with regulatory tools and could deter trafficking, while also signaling public health priorities around emerging drug threats that standard overdose reversal methods cannot address.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.